SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Teva Pharmaceuticals
TEVA 32.04-1.5%Jan 9 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug who wrote (220)6/15/1998 4:44:00 PM
From: Harold Engstrom  Read Replies (1) of 340
 
Doug, management that continually promises the rainbow over the next horizon and blames poor results on circumstances outside their control is among my least favorite company attributes. Management's job is to anticipate problems and ensure that performance is not affected by those problems.

In addition, Teva hypes its products in advance - that is probably fine for a toy manufacturer, but bad form in pharmaceuticals where the proof of the pudding is really in the eating. Braggadocio can have a devastating effect on companies whose stock in trade is credibility - like pharmaceuticals and financial concerns.

Don't like Teva's behaviour at all. Would consider buying on fundementals however, if the stock price gets ridiculously low.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext